- DKK73.14bn
- DKK92.00bn
- DKK22.97bn
Europe Research Roundup: Amplifon, Cembre, Volex
Europe Research Roundup: Applied Nutrition, Noba Bank Group, Trainline
Demant shares shine helped by organic growth beat, valuation
Brief: Demant Sees 2025 Organic Growth Likely In Lower End Of 1-3% Range
Short Take: Amplifon posts Q3 profit fall, confirms 2025 guidance
Brief: Demant to sell Oticon Medical to Impilo
Exane BNP Paribas re-initiates Sonova with 'underperform'
Brief: Demant Chair Of Board, Niels B. Christiansen, Not To Stand For Re-Election
Philips in talks with US over probes of medical technology imports (updated)
European med-tech companies slide on US tariffs fears
Europe Research Roundup: Diasorin, Kingspan Group, Nexans
Brief: Demant Revises Downwards 2025 Outlook
European hearing aid companies drop after Amplifon's Q2 results, guidance cut
Europe Research Roundup: Fincantieri, Indra, Telenor
Barclays switchers preference within European hearing aid makers, flagging US recovery risk
Europe Research Roundup: Barclays, Carlsberg, Sodexo
Top of the Street: Demant, Sonova, Bayer, Deutsche Boerse
Demant expands in German through 700 million euro Kind deal
Exane Bnp Paribas Re: evaluates medtech stocks, upgrades Demant, demotes Sonova